Data / Drug companies / Macrolide
Macrolide drugs: 5 drugs from 44 companies in the FDA NDC directory
Macrolide is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 109 products in this class from 44 companies, covering 5 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on August 13, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 44Companies
- 109Products
- 5Drugs by generic name
Drugs in the Macrolide class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Erythromycin | 81 | 36 |
| Erythromycin ethylsuccinate | 22 | 8 |
| Erythromycin lactobionate | 4 | 4 |
| Erythromycin and benzoyl peroxide | 1 | 3 |
| Erythromycin topical solution 2% | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Azurity Pharmaceuticals, Inc. | 12 | tablet, delayed release; suspension | Generic drugs (ANDA) | June 14, 2012 |
| Wilshire Pharmaceuticals, Inc. | 9 | tablet, delayed release; suspension | Generic drugs (ANDA) | August 24, 2020 |
| Amneal Pharmaceuticals NY LLC | 5 | tablet, delayed release; suspension | Generic drugs (ANDA) | November 4, 2019 |
| Bryant Ranch Prepack | 5 | for suspension; solution | Generic drugs (ANDA) | November 21, 2022 |
| Torrent Pharmaceuticals Limited | 5 | tablet, delayed release; tablet, coated | Generic drugs (ANDA) | October 21, 2024 |
| Cadila Pharmaceuticals Limited | 4 | tablet, film coated; for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Golden State Medical Supply, Inc. | 4 | tablet, coated; tablet, delayed release | Generic drugs (ANDA) | July 26, 2021 |
| NuCare Pharmaceuticals,Inc. | 4 | ointment; solution | Generic drugs (ANDA) | October 18, 2023 |
| A-S Medication Solutions | 3 | ointment; tablet, film coated | Generic drugs (ANDA) | May 4, 2021 |
| Ani Pharmaceuticals, Inc. | 3 | granule, for suspension | Generic drugs (ANDA) | March 25, 2019 |
| Asclemed USA, Inc. | 3 | ointment | Generic drugs (ANDA) | May 8, 2014 |
| Bryant Ranch Prepack | 3 | gel; swab | Generic drugs (ANDA) | July 7, 2008 |
| Padagis Israel Pharmaceuticals Ltd | 3 | gel; swab | Generic drugs (ANDA) | December 19, 2011 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | August 28, 2023 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | August 28, 2023 |
| Amneal Pharmaceuticals NY LLC | 2 | suspension | Generic drugs (ANDA) | December 2, 2023 |
| Armas Pharmaceuticals Inc. | 2 | injection, powder, lyophilized, for solution; ointment | Generic drugs (ANDA) | July 9, 2026 |
| Ascend Laboratories, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 14, 2022 |
| Kanchan Healthcare Inc | 2 | for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Modavar Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2021 |
| Nivagen Pharmaceuticals, Inc. | 2 | suspension | Generic drugs (ANDA) | February 1, 2023 |
| Orange Pharmaceuticals USA LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 5, 2019 |
| Proficient Rx LP | 2 | ointment | Generic drugs (ANDA) | July 18, 1996 |
| Redpharm Drug | 2 | ointment | Generic drugs (ANDA) | April 1, 2026 |
| Remedyrepack Inc. | 2 | ointment; tablet | Generic drugs (ANDA) | June 23, 2026 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 4, 2021 |
| Zydus Lifesciences Limited | 2 | tablet, film coated | Generic drugs (ANDA) | June 30, 2023 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 30, 2023 |
| Bausch & Lomb Incorporated | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| Cardinal Health 107, LLC | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| Direct RX | 1 | ointment | Generic drugs (ANDA) | January 1, 2014 |
| Dr. Reddy's Laboratories Inc. | 1 | capsule, delayed release pellets | Authorized generics (NDA) | September 1, 2024 |
| Fera Pharmaceuticals, LLC | 1 | ointment | Unapproved drugs for a shortage | September 27, 2023 |
| Gland Pharma Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 19, 2024 |
| Hospira, Inc. | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | May 25, 2005 |
| NuCare Pharmaceuticals, Inc. | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 6, 2011 |
| Piramal Critical Care Inc | 1 | injection, powder, for solution | Generic drugs (ANDA) | August 13, 2026 |
| Preferred Pharmaceuticals Inc. | 1 | ointment | Generic drugs (ANDA) | April 2, 2015 |
| Rising Pharma Holdings, Inc. | 1 | gel | Generic drugs (ANDA) | October 18, 2016 |
| Saptalis Pharmaceuticals, LLC. | 1 | solution | Generic drugs (ANDA) | August 14, 2024 |
| Sentiss Pharmaceuticals LLC | 1 | ointment | Generic drugs (ANDA) | April 1, 2026 |
| Sportpharm LLC | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| St. Mary's Medical Park Pharmacy | 1 | ointment | Generic drugs (ANDA) | October 18, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 24 | 22% |
| Ointment | 23 | 21.1% |
| Tablet, delayed release | 14 | 12.8% |
| Suspension | 10 | 9.2% |
| Granule, for suspension | 7 | 6.4% |
| For suspension | 6 | 5.5% |
| Gel | 5 | 4.6% |
| Solution | 4 | 3.7% |
| Tablet, coated | 4 | 3.7% |
| Injection, powder, lyophilized, for solution | 3 | 2.8% |
| Tablet | 3 | 2.8% |
| Swab | 3 | 2.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.